Key Points
- Director Anthony Pius Shen bought 7,000 shares of Vitalhub on March 30 at C$7.11 each (C$49,770 total), raising his stake to 12,470 shares — a 127.97% increase in his position.
- Vitalhub shares opened at C$6.95 and trade in a 12‑month range of C$6.67–C$14.64; the company has a market cap of ~C$439.5M, a P/E of 69.5, and 50‑/200‑day moving averages of C$8.05 and C$9.26 respectively.
- Analysts remain generally positive with mostly Buy/Outperform ratings despite recent price‑target cuts, and a consensus target price of C$13.86.
Vitalhub Corp. (TSE:VHI - Get Free Report) Director Anthony Pius Shen bought 7,000 shares of the business's stock in a transaction dated Monday, March 30th. The stock was acquired at an average cost of C$7.11 per share, for a total transaction of C$49,770.00. Following the purchase, the director owned 12,470 shares in the company, valued at approximately C$88,661.70. This trade represents a 127.97% increase in their position.
Vitalhub Stock Performance
Shares of Vitalhub stock opened at C$6.95 on Tuesday. Vitalhub Corp. has a twelve month low of C$6.67 and a twelve month high of C$14.64. The stock has a market cap of C$439.46 million, a price-to-earnings ratio of 69.50, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65. The company has a fifty day moving average price of C$8.05 and a 200 day moving average price of C$9.26.
Vitalhub (TSE:VHI - Get Free Report) last released its quarterly earnings data on Wednesday, March 18th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$31.39 million for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%. Analysts forecast that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.
Wall Street Analyst Weigh In
VHI has been the topic of several recent research reports. Raymond James Financial reduced their price target on Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 24th. ATB Cormark Capital Markets lowered their price objective on shares of Vitalhub from C$16.50 to C$15.00 and set an "outperform" rating for the company in a research report on Tuesday, March 10th. Royal Bank Of Canada dropped their price objective on shares of Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating on the stock in a research note on Monday, January 26th. Finally, Scotiabank reduced their target price on shares of Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to MarketBeat.com, Vitalhub has an average rating of "Buy" and a consensus target price of C$13.86.
Get Our Latest Stock Report on VHI
About Vitalhub
(
Get Free Report)
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
